We are live on
!
Find out more
OA
Oak Associates Portfolio holdings
AUM
$1.49B
1-Year Est. Return
34.25%
This Fund
S&P 500
This Quarter
Est. Return
+11.08%
1 Year Est. Return
+34.25%
3 Year Est. Return
+111.6%
5 Year Est. Return
+123.41%
10 Year Est. Return
+571.62%
AUM
$1.22B
AUM Growth
+$24.1M
(+2%)
Cap. Flow
-$64.8M
Cap. Flow
% of AUM
-5.33%
Top 10 Holdings %
Top 10 Hldgs %
43.43%
Holding
146
New
4
Increased
19
Reduced
40
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bio-Rad Laboratories Class A
BIO
|
+$2.29M |
| 2 |
Microchip Technology
MCHP
|
+$2.24M |
| 3 |
Diodes
DIOD
|
+$1.56M |
| 4 |
Jazz Pharmaceuticals
JAZZ
|
+$1.49M |
| 5 |
Centene
CNC
|
+$1.41M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
General Dynamics
GD
|
+$20.3M |
| 2 |
Gentex
GNTX
|
+$7.84M |
| 3 |
NVIDIA
NVDA
|
+$4.77M |
| 4 |
Oracle
ORCL
|
+$4.76M |
| 5 |
KLA
KLAC
|
+$4.51M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 44.62% |
| 2 | Healthcare | 17.06% |
| 3 | Communication Services | 12.9% |
| 4 | Financials | 11.14% |
| 5 | Consumer Discretionary | 10.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Seagate
STX
$195B
| $399K | 0.03% |
6,027
| – | – |
|
127
TransDigm Group
TDG
$70.3B
| $394K | 0.03% |
535
| – | – |
|
128
Pool Corp
POOL
$6.75B
| $353K | 0.03% |
1,030
| – | – |
|
129
Curtiss-Wright
CW
$26.6B
| $286K | 0.02% |
1,620
| – | – |
|
130
Thor Industries
THO
$3.87B
| $278K | 0.02% |
3,490
| – | – |
|
131
Tenet Healthcare
THC
$20.3B
| $251K | 0.02% |
4,221
| – | – |
|
132
Murphy USA
MUSA
$11.3B
| $223K | 0.02% |
864
| – | – |
|
133
ESAB
ESAB
$5.42B
| $214K | 0.02% |
+3,618
| New | +$207K |
|
134
CF Industries
CF
$19.2B
| $206K | 0.02% |
2,840
| – | – |
|
135
Viatris
VTRS
$20.4B
| $174K | 0.01% |
18,120
| – | – |
|
136
Charles River Laboratories
CRL
$11.1B
| – | – |
-5,284
| Closed | -$1.15M |
|
137
Dime Commercial Bancshares
DCOM
$1.8B
| – | – |
-23,676
| Closed | -$754K |
|
|
138
General Dynamics
GD
$103B
| – | – |
-81,824
| Closed | -$20.3M |
|
|
139
Gentex
GNTX
$4.94B
| – | – |
-287,392
| Closed | -$7.84M |
|
140
Huntington Ingalls Industries
HII
$12.6B
| – | – |
-5,254
| Closed | -$1.21M |
|
141
Harmony Biosciences
HRMY
$2.03B
| – | – |
-9,789
| Closed | -$539K |
|
142
Eli Lilly
LLY
$1.02T
| – | – |
-5,740
| Closed | -$2.1M |
|
|
MODV
143
DELISTED
ModivCare
MODV
| – | – |
-14,747
| Closed | -$1.32M |
|
144
QuidelOrtho
QDEL
$1.09B
| – | – |
-19,774
| Closed | -$1.69M |
|
145
Truist Financial
TFC
$63.5B
| – | – |
-10,375
| Closed | -$446K |
|
Similar funds
FAT
AIA
LFS
PIM
NAM
RIM
SB
MHS
Oak Associates's Q1 2023 Portfolio in Review
As of Q1 2023, Oak Associates held 146 positions worth $1.22B, up 2% from $1.19B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Oak Associates withdrew a net $64.8M in Q1 2023, closing 11 positions and reducing 40 holdings. Its most notable exit was General Dynamics, an estimated $20.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 45% of assets, up from 42% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, Oak Associates opened a new position in Bio-Rad Laboratories Class A worth $2.34M.
- Oak Associates's largest Q1 2023 buy was Bio-Rad Laboratories Class A: 4,890 shares worth $2.34M.
- Oak Associates added most to Microchip Technology in Q1 2023, an estimated $2.24M increase.
- Oak Associates's biggest Q1 2023 reduction was NVIDIA, cutting an estimated $4.77M.
- Oak Associates fully exited General Dynamics in Q1 2023, selling an estimated $20.3M.
- Oak Associates's ten largest holdings make up 43% of its $1.22B portfolio in Q1 2023.
- Oak Associates opened 4 new positions and closed 11 in Q1 2023.
- Oak Associates's portfolio value rose 2% quarter-over-quarter to $1.22B.
Based on Oak Associates's 13F filing for Q1 2023, filed 11 May 2023.